Zhejiang Lepu Pharmaceutical Co.,Ltd. (formerly known as Zhejiang Neo-dankong Pharmaceutical Co.,Ltd.), founded in 2001, is now located in Jiaojiang Chemical API Industrial Park, Taizhou City, Zhejiang Province. With an area of 152,000 square meters, Zhejiang Lepu is mainly engaged in the R&D, production and sales of medicines for Cardiovascular, Anti-Infectives, Oncology, Nervous System and other categories. In 2014, Lepu Medical Technology (Beijing) Co., Ltd. was introduced into the management then becoming the controlling shareholder, serving as the main pharmaceutical manufacturer/company of the comprehensive cardiovascular health platform combining with Medical Devices, Pharmaceutical, Healthcare Services and Mobile Medical. The main products of Zhejiang Lepu include Atorvastatin Calcium, Norfloxacin, Rosuvastatin Calcium, Sertraline HCl and other APIs and preparations. Zhejiang Lepu has a solid GMP system, with certifications including CFDA for China, FDA for USA , MHRA for UK, COS for EU, PMDA for Japan, KFDA for South Korea, etc. Many product categories are taking the leading positions in the world.